Semler Scientific, Inc. (SMLR)
USD 33.51
(-1.63%)
USD 33.51
(-1.63%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -57.13 Million USD | -150.91% |
| 2022 | -22.76 Million USD | 38.46% |
| 2021 | -36.99 Million USD | -70.13% |
| 2020 | -21.74 Million USD | -180.93% |
| 2019 | -7.74 Million USD | -135.72% |
| 2018 | -3.28 Million USD | -324.01% |
| 2017 | 1.46 Million USD | -26.37% |
| 2016 | 1.99 Million USD | 591.6% |
| 2015 | -405 Thousand USD | 90.48% |
| 2014 | -4.25 Million USD | -817.24% |
| 2013 | -464 Thousand USD | -29.61% |
| 2012 | -358 Thousand USD | -180.63% |
| 2011 | 444 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -7.34 Million USD | 88.29% |
| 2024 Q1 | -62.74 Million USD | -9.83% |
| 2024 Q3 | -6.56 Million USD | 11.8% |
| 2023 FY | -57.13 Million USD | -150.91% |
| 2023 Q2 | -39.29 Million USD | -673.31% |
| 2023 Q3 | -37.31 Million USD | 5.03% |
| 2023 Q4 | -57.13 Million USD | -53.1% |
| 2023 Q1 | -5.08 Million USD | 77.68% |
| 2022 Q2 | -39.74 Million USD | -4.26% |
| 2022 Q1 | -38.12 Million USD | -3.04% |
| 2022 Q4 | -22.76 Million USD | 49.7% |
| 2022 FY | -22.76 Million USD | 38.46% |
| 2022 Q3 | -45.27 Million USD | -13.9% |
| 2021 Q3 | -35.58 Million USD | -26.43% |
| 2021 Q1 | -26.09 Million USD | -20.0% |
| 2021 FY | -36.99 Million USD | -70.13% |
| 2021 Q2 | -28.14 Million USD | -7.86% |
| 2021 Q4 | -36.99 Million USD | -3.97% |
| 2020 Q4 | -21.74 Million USD | -32.22% |
| 2020 FY | -21.74 Million USD | -180.93% |
| 2020 Q1 | -11.21 Million USD | -44.87% |
| 2020 Q2 | -13.64 Million USD | -21.64% |
| 2020 Q3 | -16.44 Million USD | -20.58% |
| 2019 FY | -7.74 Million USD | -135.72% |
| 2019 Q1 | -4.54 Million USD | -38.37% |
| 2019 Q2 | -4.18 Million USD | 7.97% |
| 2019 Q3 | -8.54 Million USD | -104.26% |
| 2019 Q4 | -7.74 Million USD | 9.38% |
| 2018 Q4 | -3.28 Million USD | -162.93% |
| 2018 Q1 | 1.84 Million USD | 25.72% |
| 2018 Q2 | 58 Thousand USD | -96.85% |
| 2018 Q3 | -1.24 Million USD | -2253.45% |
| 2018 FY | -3.28 Million USD | -324.01% |
| 2017 Q3 | 2.3 Million USD | 0.66% |
| 2017 Q1 | 2.47 Million USD | 24.26% |
| 2017 FY | 1.46 Million USD | -26.37% |
| 2017 Q4 | 1.46 Million USD | -36.29% |
| 2017 Q2 | 2.28 Million USD | -7.6% |
| 2016 Q2 | 1.16 Million USD | 159.96% |
| 2016 FY | 1.99 Million USD | 591.6% |
| 2016 Q4 | 1.99 Million USD | 9.94% |
| 2016 Q1 | 447 Thousand USD | 210.37% |
| 2016 Q3 | 1.81 Million USD | 55.85% |
| 2015 FY | -405 Thousand USD | 90.48% |
| 2015 Q4 | -405 Thousand USD | 78.96% |
| 2015 Q3 | -1.92 Million USD | 21.11% |
| 2015 Q2 | -2.44 Million USD | 22.81% |
| 2015 Q1 | -3.16 Million USD | 25.73% |
| 2014 Q4 | -4.25 Million USD | 27.37% |
| 2014 Q2 | -6.33 Million USD | 14.0% |
| 2014 Q3 | -5.86 Million USD | 7.53% |
| 2014 FY | -4.25 Million USD | -817.24% |
| 2014 Q1 | -7.36 Million USD | -1488.15% |
| 2013 FY | -464 Thousand USD | -29.61% |
| 2013 Q2 | 687.99 Thousand USD | -64.84% |
| 2013 Q3 | -1.2 Million USD | -275.58% |
| 2013 Q4 | -464 Thousand USD | 61.59% |
| 2013 Q1 | 1.95 Million USD | 646.65% |
| 2012 Q4 | -358 Thousand USD | 0.0% |
| 2012 FY | -358 Thousand USD | -180.63% |
| 2011 FY | 444 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 310.952% |
| BrainsWay Ltd. | -10.32 Million USD | -453.585% |
| Cerus Corporation | 84.35 Million USD | 167.728% |
| Envoy Medical, Inc. | -3.81 Million USD | -1397.902% |
| electroCore, Inc. | -9.95 Million USD | -473.882% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -1014.732% |
| IceCure Medical Ltd | -9.93 Million USD | -475.096% |
| Inogen, Inc. | -103.56 Million USD | 44.839% |
| OrthoPediatrics Corp. | -9.26 Million USD | -516.489% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -1469.074% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | -336.205% |
| MaxCyte, Inc. | -27.76 Million USD | -105.777% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -1011.891% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -9822.417% |
| Orthofix Medical Inc. | 96.44 Million USD | 159.238% |
| PAVmed Inc | 29.08 Million USD | 296.418% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | -237.269% |
| RxSight, Inc. | -6.68 Million USD | -755.24% |
| Sight Sciences, Inc. | -102.71 Million USD | 44.38% |
| SI-BONE, Inc. | 5.72 Million USD | 1098.602% |
| TELA Bio, Inc. | -3.94 Million USD | -1346.695% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 199.667% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 16330.114% |
| Acutus Medical, Inc. | 12.27 Million USD | 565.266% |
| Talis Biomedical Corporation | -57.06 Million USD | -0.116% |
| Spectral AI, Inc. | -3.5 Million USD | -1531.819% |
| Nano-X Imaging Ltd. | -48.02 Million USD | -18.954% |
| CVRx, Inc. | -59.95 Million USD | 4.713% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 2979.326% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 4571.536% |
| Bioventus Inc. | 372.51 Million USD | 115.336% |
| Venus Concept Inc. | 74.3 Million USD | 176.89% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -461.088% |
| LivaNova PLC | 62.53 Million USD | 191.361% |
| 908 Devices Inc. | -115.09 Million USD | 50.363% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 117.814% |
| Nemaura Medical Inc. | 9.92 Million USD | 675.616% |
| NeuroPace, Inc. | 54.33 Million USD | 205.14% |
| LENSAR, Inc. | -18.31 Million USD | -211.981% |
| Apyx Medical Corporation | -5.15 Million USD | -1009.105% |
| Cutera, Inc. | 288.3 Million USD | 119.816% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 860.213% |
| BioSig Technologies, Inc. | 262 Thousand USD | 21905.344% |
| Anika Therapeutics, Inc. | -43.83 Million USD | -30.345% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -521.046% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 104.065% |
| Axonics, Inc. | -77.19 Million USD | 25.992% |
| Outset Medical, Inc. | 67.67 Million USD | 184.413% |
| IRIDEX Corporation | -4.28 Million USD | -1232.323% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 67.908% |
| IRadimed Corporation | -47.71 Million USD | -19.721% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -1787.971% |
| INVO Bioscience, Inc. | 8.45 Million USD | 776.004% |
| Telesis Bio, Inc. | 32.63 Million USD | 275.057% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -2183.253% |
| Varex Imaging Corporation | 316.9 Million USD | 118.028% |
| Quipt Home Medical Corp. | 81.73 Million USD | 169.897% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -1953.559% |
| Pulmonx Corporation | -42.36 Million USD | -34.868% |
| Dynatronics Corporation | 6.2 Million USD | 1020.853% |
| Modular Medical, Inc. | -8.04 Million USD | -610.395% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -1229.532% |
| InMode Ltd. | -135.39 Million USD | 57.805% |
| Bruker Corporation | 891.3 Million USD | 106.41% |
| Cytosorbents Corporation | 4.18 Million USD | 1466.088% |
| DexCom, Inc. | 2.02 Billion USD | 102.817% |
| Align Technology, Inc. | -840.47 Million USD | 93.203% |
| Viveve Medical, Inc. | -13.81 Million USD | -313.596% |
| ZimVie Inc. | 450.41 Million USD | 112.684% |
| Movano Inc. | -5.86 Million USD | -873.917% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 57.51% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -9822.417% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 2979.326% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 116.012% |
| Profound Medical Corp. | -18.17 Million USD | -214.272% |
| Insulet Corporation | 798.1 Million USD | 107.158% |
| enVVeno Medical Corporation | -2.21 Million USD | -2475.744% |
| Surmodics, Inc. | -12.01 Million USD | -375.529% |
| iCAD, Inc. | -21.2 Million USD | -169.367% |
| Nuwellis, Inc. | -2.81 Million USD | -1926.605% |
| Biotricity, Inc. | 23.09 Million USD | 347.394% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 161.003% |
| Aethlon Medical, Inc. | -4.5 Million USD | -1169.087% |
| InspireMD, Inc. | -8.04 Million USD | -610.131% |
| PAVmed Inc. | 29.08 Million USD | 296.418% |
| BIOLASE, Inc. | 11.34 Million USD | 603.614% |
| Beyond Air, Inc. | 6.22 Million USD | 1017.162% |
| FONAR Corporation | -14.66 Million USD | -289.558% |
| AxoGen, Inc. | 32.26 Million USD | 277.059% |
| Vivani Medical, Inc. | 42 Thousand USD | 136123.81% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -436.029% |
| Inari Medical, Inc. | -7.16 Million USD | -697.793% |
| UFP Technologies, Inc. | 40.77 Million USD | 240.114% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 1961.747% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -1097.365% |
| Tenon Medical, Inc. | -1.25 Million USD | -4452.191% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -651.118% |
| Co-Diagnostics, Inc. | -11.92 Million USD | -379.025% |
| AdaptHealth Corp. | 2.21 Billion USD | 102.576% |
| Sintx Technologies, Inc. | 905 Thousand USD | 6412.707% |
| NanoVibronix, Inc. | -3.27 Million USD | -1642.831% |
| Quanterix Corporation | -132.95 Million USD | 57.032% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -1953.559% |
| Sensus Healthcare, Inc. | -22.36 Million USD | -155.444% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 107.58% |
| TransMedics Group, Inc. | 121.13 Million USD | 147.163% |
| ReWalk Robotics Ltd. | -26.18 Million USD | -118.22% |
| NeuroMetrix, Inc. | -1.49 Million USD | -3731.477% |
| Hyperfine, Inc. | -75.61 Million USD | 24.45% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 137.539% |
| Biomerica, Inc. | -3.38 Million USD | -1587.74% |
| Bone Biologics Corporation | -3.02 Million USD | -1787.616% |
| AVITA Medical, Inc. | -26.23 Million USD | -117.791% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -3007.575% |
| Silk Road Medical, Inc | 64.42 Million USD | 188.68% |